OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
July 02, 2017
The more pharma science and technology change, the more business and policy concerns stay the same.
June 16, 2017
SK Biotek plans to operate the Swords, Ireland API manufacturing facility as a contract development and manufacturing site.
June 14, 2017
Sartorius Stedim Biotech combined the company’s ambr 15 bioreactor system with the Nova BioProfile FLEX2 cell culture analyzer for laboratory experiments.
June 07, 2017
USP describes analytical and microbiology testing required for different types of pharmaceutical water.
June 05, 2017
Cambrex announces expansions of its North Carolina API pilot plant and Kalskoga, Sweden large-scale manufacturing facility.
Increased capacity at PPD’s Richmond, VA laboratory are designed to support customers’ vaccine development programs.
Expanded storage capacity at the SGS laboratory in Mississauga, Canada increases stability testing capabilities.
June 02, 2017
Although widespread adoption of continuous bioprocessing has been slow, some processes have been an exception.
May 31, 2017
Microdermics will focus on product development and clinical activities of new drug delivery methods, while Vetter’s primary role will be in the fill and finish aspect.
May 30, 2017
BioVectra will open its new microbial fermentation and complex chemistry site, including the capability to handle high-potency APIs, by the end of 2017.